Tempus AI, Inc.
Tempus AI, Inc. TEM Peers
See (TEM) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TEM | $59.97 | +7.30% | 10.1B | -11.62 | -$5.16 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.75% |
| TMO | $416.31 | -0.40% | 157.2B | 24.42 | $17.05 | +0.49% |
| DHR | $193.30 | +0.23% | 138.4B | 37.47 | $5.16 | +0.75% |
| IDXX | $520.57 | -1.16% | 41.9B | 48.16 | $10.81 | N/A |
| A | $113.43 | +0.43% | 32.2B | 28.01 | $4.05 | +1.07% |
| IQV | $158.64 | +0.61% | 27.5B | 21.65 | $7.33 | N/A |
| MTD | $1,184.20 | +1.34% | 24.6B | 29.55 | $40.06 | N/A |
| NTRA | $148.40 | -0.97% | 20.3B | -100.95 | -$1.47 | N/A |
| DGX | $167.03 | +0.37% | 18.7B | 21.12 | $7.91 | +2.31% |
Stock Comparison
TEM vs DHR-PB Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, TEM is priced at $59.97, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, TEM's ROE is -5.31%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, TEM is more volatile compared to DHR-PB. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs TMO Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, TMO has a market cap of 157.2B. Regarding current trading prices, TEM is priced at $59.97, while TMO trades at $416.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas TMO's P/E ratio is 24.42. In terms of profitability, TEM's ROE is -5.31%, compared to TMO's ROE of +0.13%. Regarding short-term risk, TEM is more volatile compared to TMO. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs DHR Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, DHR has a market cap of 138.4B. Regarding current trading prices, TEM is priced at $59.97, while DHR trades at $193.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas DHR's P/E ratio is 37.47. In terms of profitability, TEM's ROE is -5.31%, compared to DHR's ROE of +0.07%. Regarding short-term risk, TEM is more volatile compared to DHR. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs IDXX Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, IDXX has a market cap of 41.9B. Regarding current trading prices, TEM is priced at $59.97, while IDXX trades at $520.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas IDXX's P/E ratio is 48.16. In terms of profitability, TEM's ROE is -5.31%, compared to IDXX's ROE of +0.57%. Regarding short-term risk, TEM is more volatile compared to IDXX. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs A Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, A has a market cap of 32.2B. Regarding current trading prices, TEM is priced at $59.97, while A trades at $113.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas A's P/E ratio is 28.01. In terms of profitability, TEM's ROE is -5.31%, compared to A's ROE of +0.19%. Regarding short-term risk, TEM is more volatile compared to A. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs IQV Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, IQV has a market cap of 27.5B. Regarding current trading prices, TEM is priced at $59.97, while IQV trades at $158.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas IQV's P/E ratio is 21.65. In terms of profitability, TEM's ROE is -5.31%, compared to IQV's ROE of +0.21%. Regarding short-term risk, TEM is more volatile compared to IQV. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs MTD Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, MTD has a market cap of 24.6B. Regarding current trading prices, TEM is priced at $59.97, while MTD trades at $1,184.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas MTD's P/E ratio is 29.55. In terms of profitability, TEM's ROE is -5.31%, compared to MTD's ROE of +1.21%. Regarding short-term risk, TEM is more volatile compared to MTD. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs NTRA Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, NTRA has a market cap of 20.3B. Regarding current trading prices, TEM is priced at $59.97, while NTRA trades at $148.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas NTRA's P/E ratio is -100.95. In terms of profitability, TEM's ROE is -5.31%, compared to NTRA's ROE of -0.18%. Regarding short-term risk, TEM is more volatile compared to NTRA. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs DGX Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, DGX has a market cap of 18.7B. Regarding current trading prices, TEM is priced at $59.97, while DGX trades at $167.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas DGX's P/E ratio is 21.12. In terms of profitability, TEM's ROE is -5.31%, compared to DGX's ROE of +0.13%. Regarding short-term risk, TEM is more volatile compared to DGX. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs WAT Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, WAT has a market cap of 17.2B. Regarding current trading prices, TEM is priced at $59.97, while WAT trades at $289.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas WAT's P/E ratio is 26.26. In terms of profitability, TEM's ROE is -5.31%, compared to WAT's ROE of +0.39%. Regarding short-term risk, TEM is more volatile compared to WAT. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs ILMN Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, ILMN has a market cap of 15.3B. Regarding current trading prices, TEM is priced at $59.97, while ILMN trades at $96.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas ILMN's P/E ratio is -15.95. In terms of profitability, TEM's ROE is -5.31%, compared to ILMN's ROE of -0.46%. Regarding short-term risk, TEM is more volatile compared to ILMN. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs PKI Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, TEM is priced at $59.97, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas PKI's P/E ratio is 41.45. In terms of profitability, TEM's ROE is -5.31%, compared to PKI's ROE of +0.04%. Regarding short-term risk, TEM is more volatile compared to PKI. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs ICLR Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, ICLR has a market cap of 11.6B. Regarding current trading prices, TEM is priced at $59.97, while ICLR trades at $144.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas ICLR's P/E ratio is 15.69. In terms of profitability, TEM's ROE is -5.31%, compared to ICLR's ROE of +0.08%. Regarding short-term risk, TEM is more volatile compared to ICLR. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs RVTY Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, RVTY has a market cap of 11.2B. Regarding current trading prices, TEM is priced at $59.97, while RVTY trades at $94.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas RVTY's P/E ratio is 39.23. In terms of profitability, TEM's ROE is -5.31%, compared to RVTY's ROE of +0.04%. Regarding short-term risk, TEM is more volatile compared to RVTY. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs QGEN Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, QGEN has a market cap of 10.5B. Regarding current trading prices, TEM is priced at $59.97, while QGEN trades at $48.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas QGEN's P/E ratio is 112.36. In terms of profitability, TEM's ROE is -5.31%, compared to QGEN's ROE of +0.03%. Regarding short-term risk, TEM is more volatile compared to QGEN. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs EXAS Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, EXAS has a market cap of 10.1B. Regarding current trading prices, TEM is priced at $59.97, while EXAS trades at $53.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas EXAS's P/E ratio is -9.71. In terms of profitability, TEM's ROE is -5.31%, compared to EXAS's ROE of -0.36%. Regarding short-term risk, TEM is more volatile compared to EXAS. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs MEDP Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, MEDP has a market cap of 9B. Regarding current trading prices, TEM is priced at $59.97, while MEDP trades at $314.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas MEDP's P/E ratio is 24.03. In terms of profitability, TEM's ROE is -5.31%, compared to MEDP's ROE of +0.54%. Regarding short-term risk, TEM is more volatile compared to MEDP. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs CRL Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, CRL has a market cap of 7.6B. Regarding current trading prices, TEM is priced at $59.97, while CRL trades at $154.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas CRL's P/E ratio is -250.02. In terms of profitability, TEM's ROE is -5.31%, compared to CRL's ROE of -0.01%. Regarding short-term risk, TEM is more volatile compared to CRL. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs GH Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, GH has a market cap of 5.9B. Regarding current trading prices, TEM is priced at $59.97, while GH trades at $47.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas GH's P/E ratio is -14.10. In terms of profitability, TEM's ROE is -5.31%, compared to GH's ROE of +3.69%. Regarding short-term risk, TEM is more volatile compared to GH. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs SYNH Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, TEM is priced at $59.97, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas SYNH's P/E ratio is 61.40. In terms of profitability, TEM's ROE is -5.31%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, TEM is more volatile compared to SYNH. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs RDNT Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, RDNT has a market cap of 4.3B. Regarding current trading prices, TEM is priced at $59.97, while RDNT trades at $57.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas RDNT's P/E ratio is -133.16. In terms of profitability, TEM's ROE is -5.31%, compared to RDNT's ROE of +0.03%. Regarding short-term risk, TEM is more volatile compared to RDNT. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs OLK Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, TEM is priced at $59.97, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas OLK's P/E ratio is -96.59. In terms of profitability, TEM's ROE is -5.31%, compared to OLK's ROE of -0.07%. Regarding short-term risk, TEM is more volatile compared to OLK. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs SHC Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, SHC has a market cap of 3.2B. Regarding current trading prices, TEM is priced at $59.97, while SHC trades at $11.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas SHC's P/E ratio is 124.78. In terms of profitability, TEM's ROE is -5.31%, compared to SHC's ROE of +0.06%. Regarding short-term risk, TEM is more volatile compared to SHC. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs TWST Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, TWST has a market cap of 2.2B. Regarding current trading prices, TEM is priced at $59.97, while TWST trades at $36.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas TWST's P/E ratio is -11.29. In terms of profitability, TEM's ROE is -5.31%, compared to TWST's ROE of -0.41%. Regarding short-term risk, TEM is more volatile compared to TWST. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs VIVO Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, VIVO has a market cap of 1.5B. Regarding current trading prices, TEM is priced at $59.97, while VIVO trades at $33.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas VIVO's P/E ratio is 21.09. In terms of profitability, TEM's ROE is -5.31%, compared to VIVO's ROE of +0.12%. Regarding short-term risk, TEM is more volatile compared to VIVO. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs GRAL Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, GRAL has a market cap of 1.3B. Regarding current trading prices, TEM is priced at $59.97, while GRAL trades at $36.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas GRAL's P/E ratio is -0.61. In terms of profitability, TEM's ROE is -5.31%, compared to GRAL's ROE of -0.75%. Regarding short-term risk, TEM is less volatile compared to GRAL. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs OPK Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, OPK has a market cap of 1.1B. Regarding current trading prices, TEM is priced at $59.97, while OPK trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas OPK's P/E ratio is -22.67. In terms of profitability, TEM's ROE is -5.31%, compared to OPK's ROE of -0.03%. Regarding short-term risk, TEM is more volatile compared to OPK. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs CDNA Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, CDNA has a market cap of 1.1B. Regarding current trading prices, TEM is priced at $59.97, while CDNA trades at $19.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas CDNA's P/E ratio is 17.14. In terms of profitability, TEM's ROE is -5.31%, compared to CDNA's ROE of +0.18%. Regarding short-term risk, TEM is more volatile compared to CDNA. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs NEOG Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, NEOG has a market cap of 1.1B. Regarding current trading prices, TEM is priced at $59.97, while NEOG trades at $4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas NEOG's P/E ratio is -2.21. In terms of profitability, TEM's ROE is -5.31%, compared to NEOG's ROE of -0.17%. Regarding short-term risk, TEM is more volatile compared to NEOG. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs GRALV Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, TEM is priced at $59.97, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas GRALV's P/E ratio is N/A. In terms of profitability, TEM's ROE is -5.31%, compared to GRALV's ROE of N/A. Regarding short-term risk, TEM is less volatile compared to GRALV. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs PSNL Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, PSNL has a market cap of 566.2M. Regarding current trading prices, TEM is priced at $59.97, while PSNL trades at $6.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas PSNL's P/E ratio is -4.97. In terms of profitability, TEM's ROE is -5.31%, compared to PSNL's ROE of -0.49%. Regarding short-term risk, TEM is more volatile compared to PSNL. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs FLGT Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, FLGT has a market cap of 549.2M. Regarding current trading prices, TEM is priced at $59.97, while FLGT trades at $18.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas FLGT's P/E ratio is -13.56. In terms of profitability, TEM's ROE is -5.31%, compared to FLGT's ROE of -0.04%. Regarding short-term risk, TEM is more volatile compared to FLGT. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs CSTL Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, CSTL has a market cap of 539.3M. Regarding current trading prices, TEM is priced at $59.97, while CSTL trades at $18.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas CSTL's P/E ratio is -98.32. In terms of profitability, TEM's ROE is -5.31%, compared to CSTL's ROE of -0.01%. Regarding short-term risk, TEM is more volatile compared to CSTL. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs LAB Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, LAB has a market cap of 471M. Regarding current trading prices, TEM is priced at $59.97, while LAB trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas LAB's P/E ratio is -3.87. In terms of profitability, TEM's ROE is -5.31%, compared to LAB's ROE of -0.28%. Regarding short-term risk, TEM is more volatile compared to LAB. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs MYGN Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, MYGN has a market cap of 466.4M. Regarding current trading prices, TEM is priced at $59.97, while MYGN trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas MYGN's P/E ratio is -4.52. In terms of profitability, TEM's ROE is -5.31%, compared to MYGN's ROE of -0.14%. Regarding short-term risk, TEM is more volatile compared to MYGN. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs CO Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, TEM is priced at $59.97, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas CO's P/E ratio is 5.06. In terms of profitability, TEM's ROE is -5.31%, compared to CO's ROE of +0.11%. Regarding short-term risk, TEM is less volatile compared to CO. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs FLDM Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, TEM is priced at $59.97, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas FLDM's P/E ratio is -4.74. In terms of profitability, TEM's ROE is -5.31%, compared to FLDM's ROE of -0.28%. Regarding short-term risk, TEM is less volatile compared to FLDM. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs STIM Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, STIM has a market cap of 237M. Regarding current trading prices, TEM is priced at $59.97, while STIM trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas STIM's P/E ratio is -2.73. In terms of profitability, TEM's ROE is -5.31%, compared to STIM's ROE of -2.09%. Regarding short-term risk, TEM is less volatile compared to STIM. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs NEO Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, NEO has a market cap of 177.9M. Regarding current trading prices, TEM is priced at $59.97, while NEO trades at $6.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas NEO's P/E ratio is -11.33. In terms of profitability, TEM's ROE is -5.31%, compared to NEO's ROE of -0.09%. Regarding short-term risk, TEM is more volatile compared to NEO. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs ACRS Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, ACRS has a market cap of 171.1M. Regarding current trading prices, TEM is priced at $59.97, while ACRS trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas ACRS's P/E ratio is -1.00. In terms of profitability, TEM's ROE is -5.31%, compared to ACRS's ROE of -0.92%. Regarding short-term risk, TEM is more volatile compared to ACRS. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs XGN Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, XGN has a market cap of 153M. Regarding current trading prices, TEM is priced at $59.97, while XGN trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas XGN's P/E ratio is -8.33. In terms of profitability, TEM's ROE is -5.31%, compared to XGN's ROE of -1.34%. Regarding short-term risk, TEM is more volatile compared to XGN. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs GTH Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, TEM is priced at $59.97, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas GTH's P/E ratio is -1.11. In terms of profitability, TEM's ROE is -5.31%, compared to GTH's ROE of -1.01%. Regarding short-term risk, TEM is more volatile compared to GTH. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs ATLN Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, ATLN has a market cap of 123.9M. Regarding current trading prices, TEM is priced at $59.97, while ATLN trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas ATLN's P/E ratio is -0.54. In terms of profitability, TEM's ROE is -5.31%, compared to ATLN's ROE of -42.96%. Regarding short-term risk, TEM is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs GENE Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, TEM is priced at $59.97, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas GENE's P/E ratio is -38.25. In terms of profitability, TEM's ROE is -5.31%, compared to GENE's ROE of -3.62%. Regarding short-term risk, TEM is more volatile compared to GENE. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs PRE Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, PRE has a market cap of 109.7M. Regarding current trading prices, TEM is priced at $59.97, while PRE trades at $8.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas PRE's P/E ratio is -2.21. In terms of profitability, TEM's ROE is -5.31%, compared to PRE's ROE of -0.28%. Regarding short-term risk, TEM is more volatile compared to PRE. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs SERA Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, SERA has a market cap of 109M. Regarding current trading prices, TEM is priced at $59.97, while SERA trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas SERA's P/E ratio is -3.16. In terms of profitability, TEM's ROE is -5.31%, compared to SERA's ROE of -0.51%. Regarding short-term risk, TEM is less volatile compared to SERA. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs MDXH Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, MDXH has a market cap of 108.6M. Regarding current trading prices, TEM is priced at $59.97, while MDXH trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas MDXH's P/E ratio is -2.11. In terms of profitability, TEM's ROE is -5.31%, compared to MDXH's ROE of -5.35%. Regarding short-term risk, TEM is more volatile compared to MDXH. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs PRENW Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, PRENW has a market cap of 87.9M. Regarding current trading prices, TEM is priced at $59.97, while PRENW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas PRENW's P/E ratio is N/A. In terms of profitability, TEM's ROE is -5.31%, compared to PRENW's ROE of -0.28%. Regarding short-term risk, TEM is less volatile compared to PRENW. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs VNRX Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, VNRX has a market cap of 71.7M. Regarding current trading prices, TEM is priced at $59.97, while VNRX trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas VNRX's P/E ratio is -2.56. In terms of profitability, TEM's ROE is -5.31%, compared to VNRX's ROE of +1.08%. Regarding short-term risk, TEM is less volatile compared to VNRX. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs NOTV Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, NOTV has a market cap of 63.7M. Regarding current trading prices, TEM is priced at $59.97, while NOTV trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas NOTV's P/E ratio is -0.59. In terms of profitability, TEM's ROE is -5.31%, compared to NOTV's ROE of -0.51%. Regarding short-term risk, TEM is less volatile compared to NOTV. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs BDSX Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, BDSX has a market cap of 44.9M. Regarding current trading prices, TEM is priced at $59.97, while BDSX trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas BDSX's P/E ratio is -1.14. In terms of profitability, TEM's ROE is -5.31%, compared to BDSX's ROE of -1.68%. Regarding short-term risk, TEM is less volatile compared to BDSX. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs OPGN Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, OPGN has a market cap of 37.5M. Regarding current trading prices, TEM is priced at $59.97, while OPGN trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas OPGN's P/E ratio is -0.24. In terms of profitability, TEM's ROE is -5.31%, compared to OPGN's ROE of +1.20%. Regarding short-term risk, TEM is less volatile compared to OPGN. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs DRIO Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, DRIO has a market cap of 31.8M. Regarding current trading prices, TEM is priced at $59.97, while DRIO trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas DRIO's P/E ratio is -1.30. In terms of profitability, TEM's ROE is -5.31%, compared to DRIO's ROE of -0.17%. Regarding short-term risk, TEM is less volatile compared to DRIO. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs STRRP Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, STRRP has a market cap of 29.4M. Regarding current trading prices, TEM is priced at $59.97, while STRRP trades at $9.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas STRRP's P/E ratio is -4.59. In terms of profitability, TEM's ROE is -5.31%, compared to STRRP's ROE of -0.24%. Regarding short-term risk, TEM is more volatile compared to STRRP. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs AKU Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, TEM is priced at $59.97, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas AKU's P/E ratio is -0.13. In terms of profitability, TEM's ROE is -5.31%, compared to AKU's ROE of -5.32%. Regarding short-term risk, TEM is less volatile compared to AKU. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs PRPO Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, PRPO has a market cap of 22.1M. Regarding current trading prices, TEM is priced at $59.97, while PRPO trades at $14.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas PRPO's P/E ratio is -7.10. In terms of profitability, TEM's ROE is -5.31%, compared to PRPO's ROE of -0.26%. Regarding short-term risk, TEM is less volatile compared to PRPO. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs ADVB Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, ADVB has a market cap of 16.8M. Regarding current trading prices, TEM is priced at $59.97, while ADVB trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas ADVB's P/E ratio is -4.84. In terms of profitability, TEM's ROE is -5.31%, compared to ADVB's ROE of -1.86%. Regarding short-term risk, TEM is less volatile compared to ADVB. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs CEMI Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, TEM is priced at $59.97, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas CEMI's P/E ratio is -0.63. In terms of profitability, TEM's ROE is -5.31%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, TEM is more volatile compared to CEMI. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs ENZ Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, TEM is priced at $59.97, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas ENZ's P/E ratio is -2.24. In terms of profitability, TEM's ROE is -5.31%, compared to ENZ's ROE of -0.44%. Regarding short-term risk, TEM is less volatile compared to ENZ. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs PMD Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, PMD has a market cap of 15.7M. Regarding current trading prices, TEM is priced at $59.97, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas PMD's P/E ratio is -5.24. In terms of profitability, TEM's ROE is -5.31%, compared to PMD's ROE of -0.33%. Regarding short-term risk, TEM is more volatile compared to PMD. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs INBS Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, INBS has a market cap of 14.7M. Regarding current trading prices, TEM is priced at $59.97, while INBS trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas INBS's P/E ratio is -1.60. In terms of profitability, TEM's ROE is -5.31%, compared to INBS's ROE of -1.72%. Regarding short-term risk, TEM is less volatile compared to INBS. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs TRIB Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, TRIB has a market cap of 13.8M. Regarding current trading prices, TEM is priced at $59.97, while TRIB trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas TRIB's P/E ratio is -0.41. In terms of profitability, TEM's ROE is -5.31%, compared to TRIB's ROE of +1.12%. Regarding short-term risk, TEM is less volatile compared to TRIB. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs ME Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, ME has a market cap of 13.3M. Regarding current trading prices, TEM is priced at $59.97, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas ME's P/E ratio is -0.03. In terms of profitability, TEM's ROE is -5.31%, compared to ME's ROE of -3.99%. Regarding short-term risk, TEM is less volatile compared to ME. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs BNGO Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, BNGO has a market cap of 11.4M. Regarding current trading prices, TEM is priced at $59.97, while BNGO trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas BNGO's P/E ratio is -0.06. In terms of profitability, TEM's ROE is -5.31%, compared to BNGO's ROE of -1.57%. Regarding short-term risk, TEM is more volatile compared to BNGO. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs BIAF Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, BIAF has a market cap of 9.4M. Regarding current trading prices, TEM is priced at $59.97, while BIAF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas BIAF's P/E ratio is -0.47. In terms of profitability, TEM's ROE is -5.31%, compared to BIAF's ROE of -3.68%. Regarding short-term risk, TEM is less volatile compared to BIAF. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs CNTG Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, CNTG has a market cap of 9.2M. Regarding current trading prices, TEM is priced at $59.97, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas CNTG's P/E ratio is -0.23. In terms of profitability, TEM's ROE is -5.31%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, TEM is less volatile compared to CNTG. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs BIAFW Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, BIAFW has a market cap of 8.7M. Regarding current trading prices, TEM is priced at $59.97, while BIAFW trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas BIAFW's P/E ratio is N/A. In terms of profitability, TEM's ROE is -5.31%, compared to BIAFW's ROE of -3.68%. Regarding short-term risk, TEM is less volatile compared to BIAFW. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs BGLC Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, BGLC has a market cap of 7.6M. Regarding current trading prices, TEM is priced at $59.97, while BGLC trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas BGLC's P/E ratio is -3.57. In terms of profitability, TEM's ROE is -5.31%, compared to BGLC's ROE of -0.24%. Regarding short-term risk, TEM is less volatile compared to BGLC. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs MYNZ Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, MYNZ has a market cap of 6.9M. Regarding current trading prices, TEM is priced at $59.97, while MYNZ trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas MYNZ's P/E ratio is -0.08. In terms of profitability, TEM's ROE is -5.31%, compared to MYNZ's ROE of -22.70%. Regarding short-term risk, TEM is less volatile compared to MYNZ. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs STRR Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, STRR has a market cap of 6.4M. Regarding current trading prices, TEM is priced at $59.97, while STRR trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas STRR's P/E ratio is -0.67. In terms of profitability, TEM's ROE is -5.31%, compared to STRR's ROE of -0.24%. Regarding short-term risk, TEM is more volatile compared to STRR. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs NVTA Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, TEM is priced at $59.97, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas NVTA's P/E ratio is -0.00. In terms of profitability, TEM's ROE is -5.31%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, TEM is less volatile compared to NVTA. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs NDRA Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, NDRA has a market cap of 5.3M. Regarding current trading prices, TEM is priced at $59.97, while NDRA trades at $7.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas NDRA's P/E ratio is 0.02. In terms of profitability, TEM's ROE is -5.31%, compared to NDRA's ROE of -1.96%. Regarding short-term risk, TEM is less volatile compared to NDRA. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs LMDXW Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, TEM is priced at $59.97, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, TEM's ROE is -5.31%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, TEM is less volatile compared to LMDXW. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs LMDX Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, TEM is priced at $59.97, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas LMDX's P/E ratio is -0.01. In terms of profitability, TEM's ROE is -5.31%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, TEM is less volatile compared to LMDX. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs BNR Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, BNR has a market cap of 4.9M. Regarding current trading prices, TEM is priced at $59.97, while BNR trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas BNR's P/E ratio is -1.40. In terms of profitability, TEM's ROE is -5.31%, compared to BNR's ROE of -0.39%. Regarding short-term risk, TEM is less volatile compared to BNR. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs CHEK Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, CHEK has a market cap of 4.6M. Regarding current trading prices, TEM is priced at $59.97, while CHEK trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas CHEK's P/E ratio is -0.36. In terms of profitability, TEM's ROE is -5.31%, compared to CHEK's ROE of -0.52%. Regarding short-term risk, TEM is more volatile compared to CHEK. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs DMTK Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, TEM is priced at $59.97, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas DMTK's P/E ratio is -0.04. In terms of profitability, TEM's ROE is -5.31%, compared to DMTK's ROE of -0.80%. Regarding short-term risk, TEM is less volatile compared to DMTK. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs AWH Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, AWH has a market cap of 2.9M. Regarding current trading prices, TEM is priced at $59.97, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas AWH's P/E ratio is -0.09. In terms of profitability, TEM's ROE is -5.31%, compared to AWH's ROE of +4.66%. Regarding short-term risk, TEM is less volatile compared to AWH. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs TTOO Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, TTOO has a market cap of 2.8M. Regarding current trading prices, TEM is priced at $59.97, while TTOO trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas TTOO's P/E ratio is -3.33. In terms of profitability, TEM's ROE is -5.31%, compared to TTOO's ROE of +2.06%. Regarding short-term risk, TEM is less volatile compared to TTOO. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs ISPC Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, ISPC has a market cap of 2.6M. Regarding current trading prices, TEM is priced at $59.97, while ISPC trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas ISPC's P/E ratio is -0.09. In terms of profitability, TEM's ROE is -5.31%, compared to ISPC's ROE of -2.85%. Regarding short-term risk, TEM is less volatile compared to ISPC. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs APDN Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, APDN has a market cap of 2.6M. Regarding current trading prices, TEM is priced at $59.97, while APDN trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas APDN's P/E ratio is N/A. In terms of profitability, TEM's ROE is -5.31%, compared to APDN's ROE of -2.81%. Regarding short-term risk, TEM is less volatile compared to APDN. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs SQL Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, TEM is priced at $59.97, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas SQL's P/E ratio is -0.40. In terms of profitability, TEM's ROE is -5.31%, compared to SQL's ROE of +10.89%. Regarding short-term risk, TEM is less volatile compared to SQL. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs HTGM Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, TEM is priced at $59.97, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas HTGM's P/E ratio is -0.03. In terms of profitability, TEM's ROE is -5.31%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, TEM is more volatile compared to HTGM. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs BIOC Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, TEM is priced at $59.97, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas BIOC's P/E ratio is -0.01. In terms of profitability, TEM's ROE is -5.31%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, TEM is less volatile compared to BIOC. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs SQLLW Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, SQLLW has a market cap of 117.9K. Regarding current trading prices, TEM is priced at $59.97, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas SQLLW's P/E ratio is -0.01. In terms of profitability, TEM's ROE is -5.31%, compared to SQLLW's ROE of -42.96%. Regarding short-term risk, TEM is more volatile compared to SQLLW. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs MEUSW Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, TEM is priced at $59.97, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas MEUSW's P/E ratio is N/A. In terms of profitability, TEM's ROE is -5.31%, compared to MEUSW's ROE of -3.99%. Regarding short-term risk, TEM is less volatile compared to MEUSW. This indicates potentially lower risk in terms of short-term price fluctuations for TEM.
TEM vs OCDX Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, TEM is priced at $59.97, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas OCDX's P/E ratio is -42.28. In terms of profitability, TEM's ROE is -5.31%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, TEM is more volatile compared to OCDX. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.
TEM vs DHR-PA Comparison
TEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TEM stands at 10.1B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, TEM is priced at $59.97, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TEM currently has a P/E ratio of -11.62, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, TEM's ROE is -5.31%, compared to DHR-PA's ROE of +0.07%. Regarding short-term risk, TEM is more volatile compared to DHR-PA. This indicates potentially higher risk in terms of short-term price fluctuations for TEM.